Effects of Novel Insulin Resistance Indices on Early Renal Functions in Donors

J Coll Physicians Surg Pak. 2024 Apr;34(4):429-433. doi: 10.29271/jcpsp.2024.04.429.

Abstract

Objective: To investigate the relationship between quickly calculable new insulin resistance (IR) indices used to evaluate IR in early kidney functions after donor nephrectomy.

Study design: Descriptive design. Place and Duration of the Study: Department of Urology, Ufuk University Faculty of Medicine, Ankara, Turkiye, between January 2016 and August 2021.

Methodology: The preoperative biochemical analyses of patients undergoing open donor nephrectomies and estimated glomerular filtration rates (eGFR) were recorded in the preoperative and first postoperative month. The IR indices (triglyceride glucose [TyG] index, TyG-body mass index [TyG-BMI], triglyceride/HDL cholesterol ratio [TG/HDL-C], and metabolic score for IR [METS-IR]) were computed. Additionally, the patients were separated into two categories. Group 1 had a less than 30% decrease in eGFR values in the postoperative first-month period, and group 2 had a more than 30% decrease. The relationship between variables was analysed using the Spearman correlation, and comparisons between groups were analysed using the independent t-test or Mann-Whitney U-test.

Results: A total of 107 patients were included in the study. The mean eGFR reduction rate was 31.81 ± 8.87 %. In the correlation analyses, an increase in the rate of decrease in postoperative GFR was associated with higher IR indices, specifically TyG (r = 0.19, p = 0.04), TG/HDL-C (r = 0.21, p = 0.02), and METS-IR (r = 0.21, p = 0.02). No statistically significant difference was found between the groups regarding all the calculated IR indices (p < 0.05).

Conclusion: The results suggest a possible link between increased IR and postoperative renal function decline.

Key words: Insulin resistance, Glomerular filtration rate, Donor nephrectomy, Triglyceride-Glucose index, METS-IR.

MeSH terms

  • Biomarkers
  • Blood Glucose / analysis
  • Cholesterol, HDL
  • Glucose
  • Humans
  • Insulin
  • Insulin Resistance*
  • Kidney / metabolism
  • Triglycerides

Substances

  • Insulin
  • Biomarkers
  • Blood Glucose
  • Glucose
  • Triglycerides
  • Cholesterol, HDL